Jennifer Lee

Jennifer Lee serves as the Chief Executive Officer of JLC Life Sciences, LLC since July 2018, providing expertise in global clinical and regulatory strategy, business turnaround, and product development among other services. In addition, Jennifer holds several influential positions including Board of Director at Enzyme by Design, member of the Chicago Executive Board at How Women Lead, and venture partner at The Cancer Fund, which focuses on early-stage investments in cancer research. Jennifer has previously led oncology development at Radius Health, Inc., contributing to the FDA approval of ORSERDU™ during the pandemic. Educationally, Jennifer holds an M.S. in Clinical Research and Regulatory Administration from Northwestern University and a B.S. in Biochemistry from the University of Illinois Chicago.